tirzepatide for mash Metabolic Dysfunction–Associated Steatohepatitis (MASH) & Uptick in GLP1 Use Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

Grade 3 to 4 treatment-related adverse events included hypertension (17%), neutropenia (13%), lymphopenia (12%), and anemia (10%)

Individual results vary based on diet, activity level, baseline gut health, and consistency of use

However, much more research is needed to determine whether metabolite sensing by PAMPs other than TLR4 is implicated in regulating hostmicrobe crosstalk and gut barrier integrity [147] in humans

This theory proposes that the vagus nerve has evolved to include distinct ventral and dorsal pathways associated with different behavioural states: the ventral vagal complex, related to social engagement and calm states, operates through myelinated fibres, enabling rapid response

Meals that are highly processed, full of added sugars, and low in fiber impair the post-meal release of GLP-1[4]